American Board of Clinical Lipidology Inc
Nonprofit profile at a glance
- EIN
- 593779919
- IRS 990-EZ coverage
- 2013–2025
- Forms available
- Form 990-EZ 2025, Form 990-N 2015
- Location
- Jacksonville, FL, USA
- Phone
- 9046740752
- Rating
- 71
- Verdict
- SUPPORTED
- Rating confidence
- Moderate
- Sector
- Management & Technical Assistance
Reported finances
- Revenue
- $88,315
- Expenses
- $79,572
- Assets
- $163,440
- Liabilities
- $400
Source: IRS Form 990-EZ. Selected filing: tax year 2025. Amounts in USD.
Leadership & pay
11 people listed
Executive titles in this filing
- Michael Miller MD (President)
- Kaye-Eileen Willard MD (Vice President)
- Don Wilson MD (Immediate Past President)
People named in this filing
- Michael Miller MD (President)
- Kaye-Eileen Willard MD (Vice President)
- Karen Aspry MD (Treasurer)
Selected names, not a complete roster or a statement of current roles. Open leadership details for the complete filed list.
Source: IRS Form 990-EZ. Selected filing: tax year 2025. Names and roles reflect this filing, not necessarily current officeholders.
Overview
Mission
Promote the study of lipid medicine
What it reported doing in 2025
Organize, administer and validate the education of lipid professionals; certify those lipid professionals who have demonstrated extraordinary training and competence; evaluate standards of training and education.
Operating model
- Revenue model
- Earned-program. 97% of the money available for current operations came from fees and other program revenue.
- Distribution model
- Direct operator. The filing allocates 100% of reported program-service expenses outside its grant, affiliate-payment, and member-benefit lines. This expense classification does not rule out separately announced grant awards.
The verdict
SUPPORTED - The filed numbers largely add up and a large share of available resources goes toward mission work. Program spending has declined or grown slowly and liabilities are high compared with assets.
Rating breakdown
- Financial Efficiency: 64
- Transparency & Controls: 82
- Sustainability: 58
- Growth: 60
Detailed rating inputs
Financial Efficiency
- Mission deployment rate: 61.2%; rating input score 61
- Program expense ratio: 70.1%; rating input score 70
Transparency & Controls
- Consistency checks: 100%; rating input score 100; 51st percentile among comparable filings
- Major donor itemization: Limited
Sustainability
- Operating margin: 9.9%; rating input score 60; 60th percentile among comparable filings
- Total-asset coverage ratio: 2.05; rating input score 66; 66th percentile among comparable filings
- Liabilities to assets ratio: 0; rating input score 29; 29th percentile among comparable filings
- Officer compensation ratio: 0%; rating input score 56; 56th percentile among comparable filings
Growth
- Program expense growth: -0.8% per year; rating input score 0; 45th percentile among comparable filings
- Revenue growth: 0.5% per year; rating input score 100; 52nd percentile among comparable filings
- Asset growth: 5.9% per year; rating input score 100; 59th percentile among comparable filings
Details
- Where the money goes: 61.2% of revenue deployed · 70.1% of spending went to programs
- Governance: Filed governance answers
- Accomplishments: 1 filed program accomplishment · $56K in reported program spending
- Leadership: top reported pay $0 · 11 people listed
- Consistency: 8 of 8 current checks pass
- Schedules: 2 filed schedules
- Filing history: 12 filing years from 2013 to 2025
- Contacts: How to reach this organization
- Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
- People: Everyone the filings name, and which of them the filings identify by more than a name.
Key Signals
Signals prioritize questions for review. They are not findings of misconduct.
- High — Growth: Program expense growth scored 0/100.
- High — Sustainability: Liabilities to assets ratio scored 29/100.
- Review — Sustainability: Officer compensation ratio scored 56/100.